Circulatory miRNA biomarkers of metabolic syndrome (original) (raw)

Circulating microRNAs Showed Specific Responses according to Metabolic Syndrome Components and Sex of Adults from a Population-Based Study

Paula Lima

Metabolites

View PDFchevron_right

Circulating microRNA Related to Cardiometabolic Risk Factors for Metabolic Syndrome: A Systematic Review

Paula Lima

Metabolites

View PDFchevron_right

Peripheral Blood miRome Identified miR-155 as Potential Biomarker of MetS and Cardiometabolic Risk in Obese Patients

Egidio Dorea

International Journal of Molecular Sciences

View PDFchevron_right

Circulating microRNAs have a sex-specific association with metabolic syndrome

Yi-chu Liao

Journal of Biomedical Science, 2013

View PDFchevron_right

Characterization of Differentially Expressed Circulating miRNAs in Metabolically Healthy versus Unhealthy Obesity

Joaquin Panadero

Biomedicines, 2021

View PDFchevron_right

Correlation of circulating miRNA-33a and miRNA-122 with lipid metabolism among Egyptian patients with metabolic syndrome

Inass H A S S A N Ahmad

Journal of Genetic Engineering and Biotechnology, 2021

View PDFchevron_right

Characteristic MicroRNAs Linked to Dysregulated Metabolic Pathways in Qatari Adult Subjects With Obesity and Metabolic Syndrome

Meis Alkasem

Frontiers in Endocrinology

View PDFchevron_right

Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients

Ahmed Abulsoud

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 2019

View PDFchevron_right

Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients

Mohamed ELsisi

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 2019

View PDFchevron_right

Circulating miR-216a as a biomarker of metabolic alterations and obesity in women

B Winkens

Non-coding RNA Research, 2020

View PDFchevron_right

Microrna 155 a Candidate Biomarker for Metabolic Syndrome

Anca Botezatu

Journal of Hypertension, 2011

View PDFchevron_right

The potential role of miR-27a and miR-320a in metabolic syndrome in obese Egyptian females

khalda Amr

Journal of Genetic Engineering and Biotechnology

View PDFchevron_right

Characterization of Circulating Exosomal MicroRNAs and Its Role as Biomarkers for Metabolic Syndrome

Haytham Ali

Zagazig Veterinary Journal, 2019

View PDFchevron_right

MicroRNAs and metabolic disorders - where are we heading?

Józef Drzewoski

Archives of medical science : AMS, 2017

View PDFchevron_right

Mir-1, miR-122, miR-132, and miR-133 Are Related to Subclinical Aortic Atherosclerosis Associated with Metabolic Syndrome

Tomas Krilavičius

International Journal of Environmental Research and Public Health, 2021

View PDFchevron_right

Significant role of some miRNAs as biomarkers for the degree of obesity

Abdou K Allayeh

Journal of Genetic Engineering and Biotechnology

View PDFchevron_right

Differential miRNA Expression in Omental Adipose Tissue and in the Circulation of Obese Patients Identifies Novel Metabolic Biomarkers

Nicola Miller

The Journal of Clinical Endocrinology & Metabolism, 2011

View PDFchevron_right

Circulating MicroRNA-122 is Associated With the Risk of New-Onset Metabolic Syndrome and Type-2-Diabetes

Alun Hughes

Diabetes, 2016

View PDFchevron_right

An Update on Microrna's and Metabolic Regulation with Future Therapeutic Potentials Regarding Diagnosis and Treatment of Obesity, Metabolic Syndrome and Other Related Disorders

Kulvinder K O C H A R Kaur

An Update on Microrna’s and Metabolic Regulation with Future Therapeutic PotentialsRegarding Diagnosis and Treatment of Obesity, Metabolic Syndrome and Other Related Disorders. J Health Med Informat 6: 184. doi: 10.4172/2157-7420.1000184, 2015

View PDFchevron_right

Low expression levels of miRNA-155 and miRNA-499a are associated with obesity in Type 2 diabetes

Giuseppe Novelli

Epigenomics, 2024

View PDFchevron_right

Circulating microRNAs as predictive biomarkers of coronary artery diseases in type 2 diabetes patients

Sakhavat Abolhasani

Journal of Clinical Laboratory Analysis, 2022

View PDFchevron_right

Blood-derived miRNA levels are not correlated with metabolic or anthropometric parameters in obese pre-diabetic subjects but with systemic inflammation

Muthuswamy Balasubramanyam

PLOS ONE

View PDFchevron_right

FUNCTIONAL GENOMICS: MIRNAS IN LIPID METABOLISM AND OBESITY

Justin David

View PDFchevron_right

Multi-Omics Analysis Reveals MicroRNAs Associated With Cardiometabolic Traits

Jaco Klap

Frontiers in Genetics

View PDFchevron_right

MicroRNA-155 Deficiency Leads to Decreased Atherosclerosis, Increased White Adipose Tissue Obesity, and Non-alcoholic Fatty Liver Disease

Huimin Shan

Journal of Biological Chemistry, 2016

View PDFchevron_right

The Role of Micrornas in Lipid Metabolism and their Probable Associations for Progress and Treatment of Atherosclerosis

Tanveer Tara

Pakistan Journal of Medical and Health Sciences

View PDFchevron_right

Visceral Adipose Tissue of Prediabetic and Diabetic Females Shares a Set of Similarly Upregulated microRNAs Functionally Annotated to Inflammation, Oxidative Stress and Insulin Signaling

Józef Drzewoski

Antioxidants

View PDFchevron_right